Mengis Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,330
| Closed | -$203K | – | 192 |
|
|
2024
Q4 | $203K | Sell |
1,330
-50
| -4% | -$7.65K | 0.04% | 183 |
|
|
2024
Q3 | $267K | Sell |
1,380
-1,200
| -47% | -$233K | 0.05% | 166 |
|
|
2024
Q2 | $598K | Hold |
2,580
| – | – | 0.12% | 125 |
|
|
2024
Q1 | $556K | Sell |
2,580
-5,475
| -68% | -$1.18M | 0.09% | 139 |
|
|
2023
Q4 | $2.08M | Hold |
8,055
| – | – | 0.39% | 60 |
|
|
2023
Q3 | $2.07M | Sell |
8,055
-50
| -0.6% | -$12.9K | 0.43% | 60 |
|
|
2023
Q2 | $2.31M | Hold |
8,105
| – | – | 0.46% | 57 |
|
|
2023
Q1 | $2.25M | Hold |
8,105
| – | – | 0.47% | 60 |
|
|
2022
Q4 | $2.24M | Sell |
8,105
-10
| -0.1% | -$2.77K | 0.49% | 58 |
|
|
2022
Q3 | $2.17M | Sell |
8,115
-1,800
| -18% | -$480K | 0.51% | 56 |
|
|
2022
Q2 | $2.02M | Hold |
9,915
| – | – | 0.44% | 60 |
|
|
2022
Q1 | $2.09M | Hold |
9,915
| – | – | 0.4% | 63 |
|
|
2021
Q4 | $2.38M | Sell |
9,915
-2,735
| -22% | -$656K | 0.45% | 58 |
|
|
2021
Q3 | $3.58M | Hold |
12,650
| – | – | 0.75% | 38 |
|
|
2021
Q2 | $4.38M | Hold |
12,650
| – | – | 0.91% | 31 |
|
|
2021
Q1 | $3.54M | Hold |
12,650
| – | – | 0.78% | 38 |
|
|
2020
Q4 | $3.1M | Sell |
12,650
-5,900
| -32% | -$1.44M | 0.75% | 36 |
|
|
2020
Q3 | $5.26M | Buy |
18,550
+700
| +4% | +$199K | 1.44% | 17 |
|
|
2020
Q2 | $4.78M | Buy |
17,850
+11
| +0.1% | +$2.94K | 1.42% | 16 |
|
|
2020
Q1 | $5.64M | Buy |
17,839
+1,450
| +9% | +$459K | 1.93% | 11 |
|
|
2019
Q4 | $4.86M | Hold |
16,389
| – | – | 1.34% | 20 |
|
|
2019
Q3 | $3.82M | Buy |
16,389
+1,110
| +7% | +$258K | 1.14% | 26 |
|
|
2019
Q2 | $3.57M | Buy |
+15,279
| New | +$3.57M | 1.09% | 25 |
|